Condition: Thoracic Surgery · Heart Diseases · Fibrinolysis Shutdown · Sponsor: Saint Petersburg State University, Russia
PRIORITY is a pragmatic, multi-center, cluster crossover trial that aims to evaluate whether implementing a policy of routine extended (intraoperative and 4 hour after transfer to ICU) use of fibrinolysis inhibitors leads to a decrease in post-operative blood transfusion compared to a policy that only involves intraoperative use.
This description comes directly from the study's public registry record.
Sergey Efremov, PhD · +79137946090 · efremovsergm@gmail.com
Always discuss trial participation with your own doctor first.
| Cardiac surgery department, Saint-Petersburg state university hospital | Saint Petersburg, Russia | Recruiting |
| St. Petersburg State University Hospital | Saint Petersburg, Russia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06493227